In addition, we demonstrate that as an ER-resident molecule, FKBP9 modulates the IRE1α-XBP1 pathway and confers GBM cell resistance to ER stress inducers that trigger FKBP9 ubiquitination and degradation. The gene discussed is FKBP9; the disease is glioblastoma.